Forte Biosciences (FBRX) Cash & Current Investments (2016 - 2026)
Forte Biosciences (FBRX) recorded Cash & Current Investments of $198.5 million in Q2 2026, up 87.0% from $106.14 million a year earlier and up 240.9% from the prior quarter.
Powered by 
Analysis
Forte Biosciences (FBRX) Cash & Current Investments (2016 - 2026) Analysis & Trends
At the end of FY2025, Forte Biosciences reported Cash & Current Investments of $76.96 million, up 31.8% from FY2024.
- Annual Cash & Current Investments has a five-year compound annual growth rate of 5.5% (FY2020 to FY2025).
- Across earlier years, Cash & Current Investments came in at $58.4 million in FY2024 (+57.3%), $37.13 million in FY2023 (-9.7%), $41.1 million in FY2022 (-2.2%) and $42.04 million in FY2021 (-28.5%).
- The Q2 2026 figure is the highest quarterly Cash & Current Investments in data going back to Q1 2016.
- On a year-over-year basis, Cash & Current Investments has increased for seven consecutive quarters, with growth averaging 124.0% over the last eight quarters.
- Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 469.6% in Q3 2025, against a decline of 64.5% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $58.22 million (Q1 2026), $76.96 million (Q4 2025) and $93.41 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Forte Biosciences | 1.58 Bn | 1.38 Bn | - | 198.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 198.50 Mn |
| Mar 31, 2026 | 58.22 Mn |
| Dec 31, 2025 | 76.96 Mn |
| Sep 30, 2025 | 93.41 Mn |
| Jun 30, 2025 | 106.14 Mn |
| Mar 31, 2025 | 45.90 Mn |
| Dec 31, 2024 | 58.40 Mn |
| Sep 30, 2024 | 16.40 Mn |
| Jun 30, 2024 | 24.50 Mn |
| Mar 31, 2024 | 30.44 Mn |
| Dec 31, 2023 | 37.13 Mn |
| Sep 30, 2023 | 46.20 Mn |
| Jun 30, 2023 | 30.43 Mn |
| Mar 31, 2023 | 35.90 Mn |
| Dec 31, 2022 | 41.10 Mn |
| Sep 30, 2022 | 44.05 Mn |
| Jun 30, 2022 | 38.55 Mn |
| Mar 31, 2022 | 40.04 Mn |
| Dec 31, 2021 | 42.04 Mn |
| Sep 30, 2021 | 45.70 Mn |
API Access
Forte Biosciences Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=FBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "FBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=FBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();